Poly(anhydride-co-imides): In vivo biocompatibility in a rat model

Biomaterials

Volumn 19, Issue 10, 1998, Pages 941-951

  Ibim, Sobrasua M ^a   Uhrich, Kathryn E ^b   Bronson, Roderick ^c   El Amin, Saadiq F ^d   Langer, Robert S ^e   Laurencin, Cato T ^d,f  

^a Morris Brown College   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Massachusetts Institute of Technology   (United States)

^f Drexel University   (United States)

Author keywords

Biocompatibility; Degradation; Poly(anhydride co imide); Poly(lactic acid glycolic acid) (PLAGA)

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; ENCAPSULATION; POLYESTERS; POLYIMIDES; TISSUE;

POLYANHYDRIDECOIMIDE;

IMPLANTS (SURGICAL);

IMIDE; POLYANHYDRIDE; POLYGLACTIN; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DEGRADATION; EDEMA; ENCAPSULATION; HISTOCOMPATIBILITY; HISTOLOGY; IMPLANT; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS TISSUE; SURGICAL WOUND; WEIGHT BEARING;

ACUTE-PHASE REACTION; ANIMALS; BIOCOMPATIBLE MATERIALS; HEXANES; LACTIC ACID; MACROPHAGES; MALE; NEUTROPHILS; PHAGOCYTOSIS; POLYGLYCOLIC ACID; POLYMERS; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TIME FACTORS;

EID: 0032077637     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00019-2     Document Type: Article

References (41)

1. [1] Chasin M, Domb A, Ron E, Mathiowitz E, Leong K, Laurencin C, Brem H, Grossman S, Langer R. Polyanhydrides as drug delivery systems. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker Inc., 1990:43-70.
2. [2] Mills SN, Davis SS. In: Ilium, Davis SS, editors. Controlled drug delivery. Bristol: IOP Publishing Limited, 1987:114.
3. [3] Heller J, Sparer RV, Zentner GM. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. 1998; New York: Marcel Dekker Inc.
4. [4] Allcock HR, Fuller TJ, Mack DP, Matsumura K, Smeltz KM. Synthesis of poly[(amino acid alkyl ester) phosphazenes]. Macromolecules 1977;10:824-30.
5. [5] Chasin M, Lewis D, Langer R. Poly(anhydrides) for controlled release. Biopharm Manufacturing 1988;1:33-46.
6. [6] Langer R. Polymeric delivery systems for controlled drug release. Chem Eng Commun 1980;6:1-48.
7. [7] Finn RA, Bell WH, Brammer JA. Interpositional grafting with autogenous bone and coralline hydroxyapatite. J Maxillofac Surg 1980;8:217-27.
8. [8] West TL, Brustein DD. Freeze-dried bone and coralline implants compared in the dog. J Periodontal 1985;56:348-51.
9. [9] Peicuch JF, Fedorka NJ. Results of soft tissue surgery over implanted Replamineform hydroxyapatite. J Oral Maxillofac Surg 1984;41:801-6.
10. [10] Metsger DS, Driskell TD, Paulsrud JR. Tricalcium phosphate ceramic - a resorbable bone implant: review and current status. JADA 1982;105:1035-8.
11. [11] Singh H, Vasudevan P, Misra M, Ray AR, Guha SK. Novel dose of contraception using polymeric hydrogels-I. J Biomed Mater Res 1981;16:3-6.
12. [12] Leong KW, D'Amore P, Maletta M, Langer R. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. J Biomed Mater Res 1986;20:51-64.
13. [13] Laurencin CT, Domb AJ, Morris C, Brown V, Chasin M, Mac-Connell R, Lange N, Langer R. High dose administration of polyanhydride in vivo: studies of biocompatibility and toxicology. J Biomed Mater Res 1990;24:1463-81.
14. [14] Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H. Brain biocompatibility of a biocompatible controlled-release polymer in rats. J Biomed Mater Res 1989;23:253-66.
15. [15] Staubli A, Ron E, Langer R. Hydrolytically degradable amino acid containing polymers. J Am Chem Soc 1990;112:4419-24.
16. [16] Uhrich KE, Gupta A, Thomas TT, Laurencin CT, Langer R. Synthesis and characterization of degradable poly(anhydride-coimides). Macromolecules 1995;28:2184-93.
17. [17] Leong K, Brott B, Langer R. Bioerodible poly(anhydrides) as drug-carrier matrices: I. Characterization, degradation and release characteristics. J Biomed Mater Res 1985;19:941-55.
18. [18] Refojo MF, Leong FL. Poly(methylacrylate-co-hydroxyethyla-crylate) hydrogel implant material of strength and softness. J Biomed Mater Res 1981;15:491-6.
19. [19] Coleman DL, King RN, Andrade JD. The foreign body reaction: a chronic inflammatory response. J Biomed Mater Res 1974;8:199-211.
20. [20] Attawia MA, Uhrich KE, Botchwey E, Fan M, Langer R, Laurencin CT. Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. J Biomed Mat Res 1996;29:1233-40.
21. [21] Attawia MA, Uhrich KE, Botchwey E, Langer R, Laurencin CT. In vitro bone biocompatibility of poly(anhydride-co-imides) containing pyromellitylimidoalanine. J Orthop Res 1996;14:445-54.
22. [22] Homsy CA. Biocompatibility in selection of materials for implantation. J Biomed Mater Res 1970;4:341-54.
23. [23] Turner JE, Laurence WH, Autian J. Subacute toxicity testing of biomaterials using histopathologic evaluation of rabbit muscle tissue. J Biomed Mater Res 1973;7:39-45.
24. [24] Little K, Parkhouse J. Tissue reactions to polymers. Lancet ii 1962;27:857-61.
25. [25] Wood NK, Kaminski EJ, Oglesby RJ. The significance of implant shape in experimental testing of biological materials: disc versus rods. J Biomed Mater Res 1970;4:1-12.
26. [26] Rigdon RH. Tissue reactions to foreign material. Crit Rev Food Sci Nutr 1974;7:435.
27. [27] Gourlay SJ, Rice RM, Hegyeli AF, Wade CWR, Dildon JG, Jaffe H, Kulkami RK. Biocompatibility testing of polymers: in vivo implantation studies. J Biomed Mater Res 1978;12:219-32.
28. [28] Laurencin CT, Koh HJ, Neenan RH, Allcock RH, Langer R. Controlled release using a new bioerodible polyphosphazene system. J Biomed Mater Res 1987;21:1231-46.
29. [29] Wuthrich P, Ng BK, Fritzinger KV, Heller J. Pulsatile and delayed release of lysozomes from ointment-like poly(ortho-esters). J Controlled Release 1992;21:191-200.
30. [30] Yan C, Resau JH, Hewetson J, West M, Rill WL, Kende M. Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-water emulsion technique. J Controlled Release 1994;32:231-41.
31. [31] Brady JM, Cutright DE, Miller RA, Battistone, GC, Hunsuck EE. Resorption rate, route of elimination and ultrastructure of the implant site of poly(lactic acid) in the abdominal wall of the rat. Oral Surg 1973;7:155-61.
32. [32] Hollinger JO. Preliminary report on the osteogenic potential of a biodegradable copolymer of polylactide (PLA) and polyglycolide (PGA). J Biomed Mater Res 1983;17:71-8.
33. [33] Miller RA, Brady JM, Cutright DE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res 1977;11:711-7.
34. [34] Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide)microspheres. Biomaterials 1993; 14:470-7.
35. [35] Stinson NE. Tissue reaction to poly(methylmethacrylate) in rats and guinea pigs. Nature 1960;188:678-83.
36. [36] Uhrich KE, Thomas TT, Laurencin CT, Langer R. In vitro characteristics of poly(anhydride-co-imides) containing trimellitylimidoglycine. J Appl Polym Sci (in press).
37. [37] Uhrich KE, Larrier DR, Laurencin CT, Langer R. In vitro degradation of poly(anhydride-co-imides) containing pyromellitylimidoalanine. J Polym Sci 1996;34:1261-9.
38. [38] Uhrich KE, Ibim SEM, Larrier DR, Laurencin CT, Langer R. Characterization of poly(anhydride-co-imides) following in vivo degradation studies. Manuscript in preparation.
39. [39] Autian J. Toxicological evaluation of biomaterials: primary acute toxicity screening program. Artif Organs 1977;1:53-60.
40. [40] Marion L, Haugen E, Major IA. Methodological assessment of subcutaneous implantation techniques. J Biomed Mater Res 1980;14:343-57.
41. [41] Uhrich KE, Seidel J, Laurencin CT, Langer R. Mechanical properties of poly(anhydride-imides) for orthopedic applications. Manuscript in preparation.